PL2301525T3 - Preparat ibuprofenu do stosowania miejscowego - Google Patents

Preparat ibuprofenu do stosowania miejscowego

Info

Publication number
PL2301525T3
PL2301525T3 PL09757648T PL09757648T PL2301525T3 PL 2301525 T3 PL2301525 T3 PL 2301525T3 PL 09757648 T PL09757648 T PL 09757648T PL 09757648 T PL09757648 T PL 09757648T PL 2301525 T3 PL2301525 T3 PL 2301525T3
Authority
PL
Poland
Prior art keywords
ibuprofen formulation
topical ibuprofen
topical
formulation
ibuprofen
Prior art date
Application number
PL09757648T
Other languages
English (en)
Inventor
De Blas Andrés Pinilla
Vicente Ana Ortiz
Aguirre Jaime Comín
Ibarra Esther Vayá
Enseñat Pedro González
Original Assignee
Laboratorios Alcala Farma S L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Alcala Farma S L filed Critical Laboratorios Alcala Farma S L
Publication of PL2301525T3 publication Critical patent/PL2301525T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL09757648T 2008-06-06 2009-04-30 Preparat ibuprofenu do stosowania miejscowego PL2301525T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ES200801720A ES2330295B1 (es) 2008-06-06 2008-06-06 Formulacion topica de ibuprofeno.
PCT/ES2009/070131 WO2009147269A1 (es) 2008-06-06 2009-04-30 Formulación tópica de ibuprofeno
EP09757648.2A EP2301525B1 (en) 2008-06-06 2009-04-30 Topical ibuprofen formulation

Publications (1)

Publication Number Publication Date
PL2301525T3 true PL2301525T3 (pl) 2014-01-31

Family

ID=41338228

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09757648T PL2301525T3 (pl) 2008-06-06 2009-04-30 Preparat ibuprofenu do stosowania miejscowego

Country Status (6)

Country Link
US (1) US20090304782A1 (pl)
EP (1) EP2301525B1 (pl)
ES (1) ES2330295B1 (pl)
PL (1) PL2301525T3 (pl)
PT (1) PT2301525E (pl)
WO (1) WO2009147269A1 (pl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10695431B2 (en) 2010-10-29 2020-06-30 Infirst Healthcare Limited Solid solution compositions and use in cardiovascular disease
US9271950B2 (en) 2010-10-29 2016-03-01 Infirst Healthcare Limited Compositions for treating chronic inflammation and inflammatory diseases
US11202831B2 (en) 2010-10-29 2021-12-21 Infirst Healthcare Limited Solid solution compositions and use in cardiovascular disease
US11224659B2 (en) 2010-10-29 2022-01-18 Infirst Healthcare Limited Solid solution compositions and use in severe pain
US9744132B2 (en) 2010-10-29 2017-08-29 Infirst Healthcare Limited Solid solution compositions and use in chronic inflammation
US8895537B2 (en) 2010-10-29 2014-11-25 Infirst Healthcare Ltd. Compositions and methods for treating cardiovascular diseases
US10695432B2 (en) 2010-10-29 2020-06-30 Infirst Healthcare Limited Solid solution compositions and use in severe pain
US9504664B2 (en) 2010-10-29 2016-11-29 Infirst Healthcare Limited Compositions and methods for treating severe pain
US11730709B2 (en) 2010-10-29 2023-08-22 Infirst Healthcare Limited Compositions and methods for treating severe pain
US9308213B2 (en) 2010-10-29 2016-04-12 Infirst Healthcare Limited Solid solution compositions and use in chronic inflammation
US9737500B2 (en) 2010-10-29 2017-08-22 Infirst Healthcare Limited Compositions and methods for treating severe pain
CN102579350B (zh) * 2012-03-02 2013-04-24 海南灵康制药有限公司 右旋布洛芬脂质体固体制剂
US20140328898A1 (en) * 2013-03-15 2014-11-06 Children's National Medical Center Nano-Liposomal Formulations and Methods of Use
US11007161B1 (en) 2014-12-31 2021-05-18 Eric Morrison Ibuprofen nanoparticle carriers encapsulated with hermatic surfactant films
US10561627B2 (en) 2014-12-31 2020-02-18 Eric Morrison Ibuprofen nanoparticle carriers encapsulated with hermetic surfactant films
US10596117B1 (en) 2014-12-31 2020-03-24 Eric Morrison Lipoleosomes as carriers for aromatic amide anesthetic compounds
CN116370428A (zh) * 2023-04-28 2023-07-04 济南市中西医结合医院 一种布洛芬缓释片、制备方法及用途

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3421468A1 (de) * 1984-06-08 1985-12-19 Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim Lipidnanopellets als traegersystem fuer arzneimittel zur peroralen anwendung
DE3522550A1 (de) * 1985-06-24 1987-01-02 Klinge Co Chem Pharm Fab Aufspruehbare pharmazeutische zubereitung fuer die topische anwendung
EP0225162B1 (en) 1985-11-27 1992-01-22 Ethicon, Inc. Inhibition of post-surgical adhesion formation by the topical administration of non-steroidal anti-inflammatory drug
US4877619A (en) * 1986-08-25 1989-10-31 Vestar, Inc. Liposomal vesicles for intraperitoneal administration of therapeutic agents
GB2217596A (en) 1988-04-26 1989-11-01 American Cyanamid Co Anti-arthritic liposome composition
US5036046A (en) 1988-10-12 1991-07-30 Eye Research Institute Of Retina Foundation, Inc. Method for enhancing healing of corneal endothelial wounds
DK0560900T3 (da) 1990-12-03 1995-05-08 Nexstar Pharmaceuticals Inc Forebyggelse af synovialadhæsioner
GB9212511D0 (en) 1992-06-12 1992-07-22 Cortecs Ltd Pharmaceutical compositions
AU4327193A (en) 1992-07-08 1994-01-31 Dianorm-Gerate G. Maierhofer Liposomes, method of preparing them and their use in the preparation of drugs
US5785976A (en) * 1993-03-05 1998-07-28 Pharmacia & Upjohn Ab Solid lipid particles, particles of bioactive agents and methods for the manufacture and use thereof
US5654337A (en) 1995-03-24 1997-08-05 II William Scott Snyder Topical formulation for local delivery of a pharmaceutically active agent
US5827533A (en) * 1997-02-06 1998-10-27 Duke University Liposomes containing active agents aggregated with lipid surfactants
DE19852928C1 (de) * 1998-11-17 2000-08-03 Steffen Panzner Strukturen in Form von Hohlkugeln
US7473432B2 (en) * 2002-10-11 2009-01-06 Idea Ag NSAID formulations, based on highly adaptable aggregates, for improved transport through barriers and topical drug delivery
US7132452B2 (en) 2003-03-10 2006-11-07 Fang-Yu Lee Topical formulation having effects on alleviating pain/inflammation caused by herpes virus infection
CA2500907A1 (en) 2005-03-15 2006-09-15 Alpharx Inc. Vehicle for topical delivery of anti-inflammatory compounds
US20060222695A1 (en) * 2005-04-01 2006-10-05 Filiberto Zadini Deoxycholic acid liposome-based dermatological topical preparation
US20080132751A1 (en) * 2006-11-30 2008-06-05 Betazone Laboratories, Inc. Compositions and methods for treatment of pain

Also Published As

Publication number Publication date
US20090304782A1 (en) 2009-12-10
ES2330295A1 (es) 2009-12-07
EP2301525B1 (en) 2013-09-11
EP2301525A4 (en) 2013-01-16
EP2301525A1 (en) 2011-03-30
WO2009147269A1 (es) 2009-12-10
PT2301525E (pt) 2013-10-16
ES2330295B1 (es) 2010-09-23

Similar Documents

Publication Publication Date Title
IL276622A (en) Antibody formulation
PL2301525T3 (pl) Preparat ibuprofenu do stosowania miejscowego
EP2504034A4 (en) TOPICAL IBUPROFEN FORMULATIONS
TWI367110B (en) Topical pharmaceutical formulation
IL217154A0 (en) Topical composition containing ibuprofen
GEP20135845B (en) Orally-disintegrating solid formulation
EP2358392A4 (en) ANTIBODY FORMULATION
EP2303265A4 (en) STABLE TOPICAL FORMULATION COMPRISING VORICONAZOLE
GB0709513D0 (en) Topical formulations
ZA201004439B (en) Formulation
HK1161552A1 (en) Pharmaceutical topical compositions
GB201020601D0 (en) Topical formulation
GB0707463D0 (en) Formulation
GB0822633D0 (en) Formulation
EP2306998A4 (en) PHARMACEUTICAL FORMULATION
EP2124938A4 (en) TOPICAL FORMULATION
EP2265268A4 (en) STABLE TOPICAL FORMULATION IN THE FORM OF FIXED DOSES
ZA201004772B (en) Novel formulation
GB0806119D0 (en) Gel formulation
GB0715723D0 (en) Formulation
GB0814376D0 (en) Formulation
GB0712972D0 (en) Formulation
GB0808196D0 (en) Topical composition
ZA200806951B (en) Homeopathy-based formulation
HK1202263A1 (en) Topical composition containing ibuprofen